Quotient
AliveDx Gets IVDR CE Mark for Allergy Immunoassay
The test is designed to detect specific immunoglobulins E to a range of protein allergens in a single blood sample, according to the Swiss company.
AliveDx Gets IVDR Certification for Switzerland, UK Manufacturing Sites
The firm said its facilities in Eysins, Switzerland, and Edinburgh, UK, have been certified under the EU's IVDR for sales of diagnostic solutions.
AliveDx Nabs CE Marks for Connective Tissue Disease Tests
AliveDx, formerly Quotient, received the regulatory clearance for a pair of immunoassays designed for use on its fully automated MosaiQ microarray platform.
Quotient Limited Voluntarily Delisting Shares From Nasdaq, Laying off 100 Employees
The move would take company shares off the exchange by early January, ending efforts earlier this year to regain compliance with listing requirements.
Quotient Limited Completes 1-For-40 Reverse Stock Split
The split is intended to bring the company into compliance with the minimum bid price requirement for the Nasdaq Global Market.
Jun 24, 2022
Quotient Limited Fiscal Q4 Revenues Up 2 Percent
Jun 8, 2022
Quotient, Theradiag Announce Dx Partnership
Jul 9, 2021